# Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

> **NCT00004465** · PHASE3 · TERMINATED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 145 (actual)

## Conditions studied

- Hemolytic Uremic Syndrome

## Interventions

- **DRUG:** SYNSORB Pk
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00004465
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-07-27
- **Primary completion:** 2001-04-14
- **Final completion:** 2001-04-14
- **Target enrollment:** 145 (ACTUAL)
- **Why stopped:** Lack of efficacy at review by DSMB using pre-specified monitoring criteria
- **Last updated:** 2017-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004465, "Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*